Contributions of adenosine receptor activation to the ocular actions of epinephrine

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 9, 1999, Pages 2054-2061

  Crosson, Craig E ^a,b   Petrovich, Margaret ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; ADRENALIN; PURINE DERIVATIVE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GLAUCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADENOSINE; ADRENERGIC AGONISTS; ANIMALS; AQUEOUS HUMOR; EPINEPHRINE; INOSINE; INTRAOCULAR PRESSURE; OPHTHALMIC SOLUTIONS; PUPIL; RABBITS; RECEPTORS, PURINERGIC P1; THEOBROMINE; THEOPHYLLINE;

EID: 0032818854     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bill A. Early effects of epinephrine on aqueous humor dynamics in vervet monkeys (Cercopithecus ethiops). Exp Eye Res. 1969;8:35-43.
2. Erickson-Lamy KA, Nathanson JA. Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro. Invest Ophthalmol Vis Sci. 1992;33:2672-2678.
3. Kacere RD, Dolan JW, Brubaker RF. Intravenous epinephrine stimulates aqueous formation in the human eye. Invest Ophthalmol Vis Sci. 1992;33:2861-2865.
4. Neufeld AH, Jampol LM, Sears ML. Cyclic-AMP in the aqueous humor: the effects of adrenergic agents. Exp Eye Res. 1972;14: 242-250.
5. Camras CB, Bhuyan KC, Podos SM, Bhuyan DK, Master RW. Multiple dosing of prostaglandin F2 alpha or epinephrine on cynomolgus monkey eyes, II: slit-lamp biomicroscopy, aqueous humor analysis, and fluorescein angiography. Invest Ophthalmol Vis Sci. 1987;28:921-926.
6. Miyake K, Shirasawa E, Hikita M, Miyake Y, Kuratomi R. Synthesis of prostaglandin E in rabbit eyes with topically applied epinephrine. Invest Ophthalmol Vis Sci. 1988;29:332-334.
7. Bito LZ, Draga A, Blanco J, Camras CB. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes. Invest Ophthalmol Vis Sci. 1983;24:312-319.
8. Stern FA, Bito LZ. Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2 alpha on cat and rhesus monkey eyes. Invest Ophthalmol Vis Sci. 1982;22:588-598.
9. Camras CB, Podos SM. The role of endogenous prostaglandins in clinically-used and investigational glaucoma therapy. Prog Clin Biol Res. 1989;312:459-475.
10. Camras CB, Feldman SG, Podos SM, et al. Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans. Am J Ophthalmol. 1985;100: 169-175.
11. Crawford KS, Gange SJ, Gabelt BT, et al. Indomethacin and epinephrine effects on outflow facility and cyclic adenosine monophosphate formation in monkeys. Invest Ophthalmol Vis Sci. 1996;37:1348-1359.
12. Zhou QY, Li C, Olah ME, et al. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci USA. 1992;89:7432-7436.
13. Maenhaut C, Van Sande J, Libert F, et al. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun. 1990;173:1169-1178.
14. Libert F, Schiffmann SN, Lefort A, et al. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J. 1991;10:1677-1682.
15. Bruns RF, Lu GH, Pugsley TA. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986;29:331-346.
16. Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB. Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res. 1997;65:595-602.
17. Wax MB, Patil RV. Immunoprecipitation of A1 adenosine receptor-GTP-binding protein complexes in ciliary epithelial cells. Invest Ophthalmol Vis Sci. 1994;35:3057-3063.
18. Crosson CE. Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther. 1995;273:320-326.
19. Tian B, Gabelt BT, Crosson CE, Kaufman PL. Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp Eye Res. 1997;64:979-989.
20. Crosson CE, Gray T. Adenosine agonists alter aqueous flow and outflow facility in rabbits [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S821. Abstract nr 3823.
21. Barany EH. Simultaneous measurements of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
22. Crosson CE, Gray T. Characterization of ocular hypertension induced by adenosine agonists. Invest Ophthalmol Vis Sci. 1996;37: 1833-1839.
23. Dunwiddie TV, Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J Pharmacol Exp Ther. 1994;268: 537-545.
24. Bardenheuer H, Schrader J. Relationship between myocardial oxygen consumption, coronary flow, and adenosine release in an improved isolated working heart preparation of guinea pigs. Circ Res. 1983;52:263-271.
25. Headrick JP, Ely SW, Matherne GP, Berne RM. Myocardial adenosine, flow, and metabolism during adenosine antagonism and adrenergic stimulation. Am J Physiol. 1993;264(1, pt 2):H61-H70. Published erratum appears in Am J Physiol. 1993;264(6, pt 2): section H, following table of contents.
26. Stone TW, Newby AC, Lloyd GE. Adenosine release. In: Williams M, ed. Adenosine and Adenosine Receptors. Clifton, NJ: Humana Press; 1990:173-223.
27. Brundege JM, Diao L, Proctor WR, Dunwiddie TV. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology. 1997;36:1201-1210.
28. Borchardt RT. N- and O-methylation. In: Jakoby WB, ed. Enzymatic Basis of Detoxification. New York, NY: Academic Press; 1980:43-62.
29. Crosson CE. Ocular hypotensive activity of the adenosine agonist (R)-phenylisopropyladenosine in rabbits. Curr Eye Res. 1992;11: 453-458.
30. Crosson CE, Gray T. Modulation of intraocular pressure by adenosine agonists. J Ocul Pharmacol. 1994;10:379-383.
31. Bruns RF, Daly JW, Snyder SH. Adenosine receptors in brain membranes: binding of N6- cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci USA. 1980;77: 5547-5551.
32. Rowland JM, Potter DE. Adrenergic drugs and intraocular pressure: the hypertensive effect of epinephrine. Ophthalmic Res. 1980;12: 221-229.
33. Crosson CE, PS. Activation of MAP kinase in human trabecular meshwork cells by the A1 agonist cyclohexyladenosine [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S800. Abstract nr 3703.
34. Crosson CE, Gray T. Response to prejunctional adenosine receptors is dependent on stimulus frequency. Curr Eye Res. 1997;16: 359-364.
35. Farahbakhsh NA, Cilluffo MC. Synergistic increase in Ca2+ produced by A1 adenosine and muscarinic receptor activation via a pertussis-toxin-sensitive pathway in epithelial cells of the rabbit ciliary body. Exp Eye Res. 1997;64:173-179.